SCHEMBL5780741

SCHEMBL5780741

[c]1n[nH]c2cccc(-c3nc4ccccc4s3)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.50
▸ NPC1 O15118 6/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ ALDH1A1 P00352 6/20 0.50
▸ MAPT P10636 4/20 0.50
▸ GAA P10253 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ ILK Q13418 7/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GLA P06280 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ APP P05067 1/20 0.43
▸ MMP9 P14780 1/20 0.43
▸ MMP8 P22894 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ HCRTR1 O43613 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5101469 0.75 KDM4E (0.54) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL231307 0.75 KDM4E (0.75) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL543407 0.74 NPC1 (0.45) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL3398344 0.73 KDM4E (0.51) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL12854008 0.73 KDM4E (0.72) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL1812287 0.72 NPC1 (0.54) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL1323935 0.72 KDM4E (0.50) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL1770412 0.72 KDM4E (0.33) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL2225061 0.71 KDM4E (0.64) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL30689066 0.71 KDM4E (0.64) KDM4ENPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2909189-A1 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt Janssen Pharmaceutica, N.V. (BE) 2015-08-26 — — EP claimed
WO-2014062655-A1 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2014-04-24 — — WO claimed
EP-1638945-A1 HETEROCYCLICALLY SUBSTITUTED PENTANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS Schering Aktiengesellschaft (DE) 2006-03-29 — — EP claimed
WO-2005003098-A1 HETEROCYCLICALLY SUBSTITUTED PENTANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-01-13 — — WO claimed
WO-2016065583-A1 OXAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2016-05-06 — — WO disclosed
EP-2909192-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T Janssen Pharmaceutica, N.V. (BE) 2015-08-26 — — EP disclosed
WO-2014062658-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T JANSSEN PHARMACEUTICA NV (BE) 2014-04-24 — — WO disclosed
Send feedback